Autoimmune arthritis: the interface between the immune system and joints

Area of Science:

• Immunology
• Rheumatology
• Osteoimmunology

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease causing chronic joint inflammation, synovial hyperplasia, and eventual cartilage/bone destruction.
• CD4(+) T cells, especially T helper 17 (Th17) cells, are implicated in RA pathogenesis.
• The precise mechanisms linking systemic immune responses to local joint pathology in RA remain under investigation.

Purpose of the Study:

• To elucidate the role of interactions between immune cells and joint-specific mesenchymal cells in RA.
• To understand how these interactions contribute to both the inflammatory and bone destruction phases of RA.
• To explore the potential for targeting these cellular interactions for novel therapeutic strategies.

Main Methods:

• Review of existing research on RA pathogenesis, focusing on CD4(+) T cell subsets and mesenchymal cell interactions.
• Analysis of findings from animal models of RA.
• Integration of recent advances in osteoimmunology.

Main Results:

• Joint-specific mesenchymal cells promote Th17 cell migration and proliferation, augmenting RA inflammation.
• Mesenchymal cells facilitate Th17-driven osteoclast differentiation, contributing to bone destruction in RA.
• The interplay between CD4(+) T cells and nonhematopoietic mesenchymal cells is critical in both RA phases.

Conclusions:

• The interaction between CD4(+) T cells and joint mesenchymal cells is a key driver of RA pathogenesis.
• Understanding this interaction provides insights into how systemic immunity causes local joint damage in RA.
• Targeting this cellular crosstalk offers a promising avenue for developing new RA therapies.